Newsletter | March 20, 2023

03.20.23 -- How To Improve Your CDMO Service Agreement
 
New Podcast Episode
Featured Articles
Why Life Sciences Boards Need More Women
 

As more women rise to senior executive positions in the field, they want to have more of a leadership role. That next step is a seat on the board — and multiple boards. It’s a natural progression.
Make The Service Agreement Work For You And Your CDMO
 

The purpose of this article is to provide practical tips for drafting robust and balanced CDMO service agreements.
Making The Right Deal For Biohaven
 

Biohaven CEO Vlad Coric describes the events leading up to Pfizer’s $11.6 billion acquisition, his drug launch during the start of COVID-19, and why company titles and seniority don’t really matter.
Video
Introducing ARW On RNA!

Hosted by Cell & Gene Collaborative's Director Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. How can the game of RISK, Harry Potter, and Michelangelo's David bring clarity to the inner workings of the mRNA + RNA therapeutics industry? Join us for a wild ride through pop culture and its potential to further our understanding of these therapeutics.
Web-Exclusive Content
Insulin's 100-Year History Inspires Today's Biotech Industry
 

Former FDA regulator Jeffrey C. Baker, Ph.D., has been speaking on the history of insulin, the first biologic, at seminars and conferences for years. This year, those talks seem more important as we mark the 100th anniversary of this life-saving drug. Baker says insulin's story holds inspiration for today's biotech companies.
Industry Insights
Nasal Delivery Technology, QbD Processes, And Outsourcing

Understand the advantages of unit/bi-dose nasal delivery technology, application of QbD process for inhaled product development, and why to outsource inhalation development and manufacturing.
Bending The “Commercialization Curve” In Large Pharma

To tackle commercialization in large pharma, explore agility to support the changing pipeline landscape, a single-partner outsourcing model, tapping into supplemental revenue streams, and gaining competitiveness in digital.
The Advantages And Challenges Of Fixed-Dose Combination Products

Understanding the significant competitive advantages of FDC products and the difficulties and potential pitfalls associated with their development and manufacturing in oral solid dosage forms is critical.
Early Plasmid Optimization For Long-Term Commercial Success

Securing the right plasmid for an application can be a complex endeavor. Core to this is selecting a supplier with the quality assurance protocols and GMPs to facilitate optimized plasmid production.
Leveraging Clinical Trial Data In Real Time To Effect Change And Mitigate Risk

Learn how clinical trial data gathering, contextualization, and analysis can all benefit from existing — but underutilized — technologies and resources.
Digital Edition
March 2023 Digital Edition
 

Inside you will find more on:

  • Startup Profiles
  • Drug Development Strategies
  • Legal Issues For The Industry
  • CEO Corner

View the digital edition.
Contribute To Life Science Leader
Article Submission Guidelines
 

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.